Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
140
Publications avec texte intégral
Open Access
53 %
Mots clés
Knockout
Myotonic dystrophy
Endurance training
Dynamin 2
Motoneuron
Dilated cardiomyopathy
Myelin
Autophagy
Glucocorticoid-receptor
ACETYLCHOLINESTERASE
DMPK
Diaphragm
PCR
Heart failure
Transgenic mouse
DM1
Aging
ARN
Alternative splicing
Myotonic Dystrophy Type 1
Gene therapy
Astrocyte
Trinucleotide Repeat Expansion
Myostatin
Heart
CRISPRi
Centronuclear myopathy
Gene editing
Antisense oligonucleotides
Hypoxia
Cardiac muscle
Glial cells
Skeletal muscle
Dystrophin
AAV
CRISPR/Cas9
Glutamate
Fibrosis
In vivo
Thérapie génique
CTG repeat contractions
MBNL
Desmin
Dystrophie Myotonique
Acetylcholinesterase knockout mouse
Myotonic dystrophy mouse models
Mouse model
Oligodendrocyte
Trinucleotide repeat expansion
CONGENITAL MYATHENIC SYNDROME
Therapy
Duchenne muscular dystrophy
Astrocytes
CTG repeats
Neuron
Brain
Male
Dystrophie myotonique
PacBio
Transgenic mouse model
Exercice
CMS
Central nervous system
Acute coronary syndrome
RNA interference
CTG repeat instability
Intermediate filament
Brain dysfunction
Exercise
GABA
Cell penetrating peptide
Oligodendrocytes
Acetylcholinesterase deficiency
BIOLOGIE MOLECULAIRE
Muscle
Animals
Cytoskeleton
Antisense oligonucleotide
Cell model
Maximal force
Expression
Glucocorticoids
Humans
Cell culture model
Myotonic Dystrophy type 1
Gene Therapy
Long read sequencing
Muscular dystrophy
GSK3
Myotonic dystrophy type 1
Mice
Mouse models
Genotype phenotype correlation
DMSXL mice
KNOCKOUT MICE
Myotonic Dystrophy
RNA biology
Quantitative microdialysis
RNA splicing
Transcriptomics